The diagnostic value of the interstitial biomarkers kl-6 and sp-d for the degree of fibrosis in combined pulmonary fibrosis and emphysema

Pulmonary Medicine

Volumn , Issue , 2012, Pages

  Chiba, Shigeki ^a   Ohta, Hiromitsu ^a   Abe, Kyoko ^a   Hisata, Shu ^a   Ohkouchi, Shinya ^a   Hoshikawa, Yasushi ^b   Kondo, Takashi ^b   Ebina, Masahito ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; KL 6; SURFACTANT PROTEIN D; UNCLASSIFIED DRUG;

AGED; ARTICLE; CLINICAL ARTICLE; COMBINED PULMONARY FIBROSIS AND EMPHYSEMA; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE COURSE; EMPHYSEMA; FEMALE; HUMAN; LUNG FIBROSIS; LUNG FUNCTION TEST; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TOTAL LUNG CAPACITY; VITAL CAPACITY;

EID: 84873167336     PISSN: 20901836     EISSN: 20901844     Source Type: Journal    
DOI: 10.1155/2012/492960     Document Type: Article

References (23)

1. Wiggins J., Strickland B., Turner-Warwick M., Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment Respiratory Medicine 1990 84 5 365 369 (Pubitemid 20287410)
2. Cottin V., Nunes H., Brillet P. Y., Delaval P., Devouassaoux G., Tillie-Leblond I., Israel-Biet D., Court-Fortune I., Valeyre D., Cordier J. F., Carré P., Chabot F., Chatté G., Cotmeur D., Crestani B., Dalphin J. C., Dietemann A., Gentil B., Humbert M., Lacronique J., Mairesse M., Marchand E., Reynaud-Gaubert M., Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity European Respiratory Journal 2005 26 4 586 593 (Pubitemid 41448654)
3. Meja M., Carrillo G., Rojas-Serrano J., Estrada A., Surez T., Alonso D., Barrientos E., Gaxiola M., Navarro C., Selman M., Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension Chest 2009 136 1 10 15
4. Kitaguchi Y., Fujimoto K., Hanaoka M., Kawakami S., Honda T., Kubo K., Clinical characteristics of combined pulmonary fibrosis and emphysema Respirology 2010 15 2 265 271
5. Lee C.-H., Kim H. J., Park C. M., Lim K. Y., Lee J. Y., Kim D. J., Yeon J. H., Hwang S.-S., Kim D.-K., Lee S.-M., Yim J.-J., Yang S.-C., Yoo C.-G., Chung H. S., Kim Y. W., Han S. K., Shim Y.-S., The impact of combined pulmonary fibrosis and emphysema on mortality International Journal of Tuberculosis and Lung Disease 2011 15 8 1111 1116
6. Wells A. U., Desai S. R., Rubens M. B., Goh N. S. L., Cramer D., Nicholson A. G., Colby T. V., Du Bois R. M., Hansell D. M., Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography American Journal of Respiratory and Critical Care Medicine 2003 167 7 962 969 (Pubitemid 36408161)
7. Ohnishi H., Yokoyama A., Kondo K., Hamada H., Abe M., Nishimura K., Hiwada K., Kohno N., Comparative study of KL-6, surfactant protein-A, surfactantprotein-D, and monocyte chemoattractant protein-1 as serum markersfor interstitial lung diseases American Journal of Respiratory and Critical Care Medicine 2002 165 3 378 381 (Pubitemid 34118512)
8. Kohno N., Inoue Y., Hamada H., Fujioka S., Fujino S., Yokoyama A., Hiwada K., Ueda N., Akiyama M., Difference in sero-diagnostic values among KL-6-associated mucins classified as cluster 9 International Journal of Cancer 1994 57 8 81 83 (Pubitemid 24188964)
9. Seko A., Ohkura T., Ideo H., Yamashita K., Novel O-linked glycans containing 6'sulfo-Gal/GalNAc of MUC1 secreted from human breast cancer YMBS cells: possible carbohydrate epitopes of KL-6(MUC1) monoclonal antibody Glycobiology 2012 22 2 181 195
10. Hermans C., Bernard A., Lung epithelium-specific proteins: characteristics and potential applications as markers American Journal of Respiratory and Critical Care Medicine 1999 159 2 648 678 (Pubitemid 29084894)
11. Usui K., Tanai C., Tanaka Y., Noda H., Ishihara T., The prevalence of pulmonary fibrosis combined with emphysema in patients with lung cancer Respirology 2011 16 2 326 331
12. Mushiroda T., Wattanapokayakit S., Takahashi A., Nukiwa T., Kudoh S., Ogura T., Taniguchi H., Kubo M., Kamatani N., Nakamura Y., A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis Journal of Medical Genetics 2008 45 10 654 656
13. Alder J. K., Chen J. J. L., Lancaster L., Danoff S., Su S. C., Cogan J. D., Vulto I., Xie M., Qi X., Tuder R. M., Phillips J. A., Lansdorp P. M., Loyd J. E., Armanios M. Y., Short telomeres are a risk factor for idiopathic pulmonary fibrosis Proceedings of the National Academy of Sciences of the United States of America 2008 105 35 13051 13056
14. Amsellem V., Gary-Bobo G., Marcos E., Maitre B., Chaar V., Validire P., Stern J.-B., Noureddine H., Sapin E., Rideau D., Hue S., le Corvoisier P., le Gouvello S., Dubois-Rande J.-L., Boczkowski J., Adnot S., Telomere dysfunction causes sustained inflammation in chronic obstructive pulmonary disease American Journal of Respiratory and Critical Care Medicine 2011 184 12 1358 1366
15. Jang J. S., Choi Y. Y., Lee W. K., Telomere length and the risk of lung cancer Cancer Science 2008 99 7 1385 1389 (Pubitemid 351761728)
16. Hirasawa Y., Kohno N., Yokoyama A., Kondo K., Hiwada K., Miyake M., Natural autoantibody to MUC1 is a prognostic indicator for non-small cell lung cancer American Journal of Respiratory and Critical Care Medicine 2000 161 2 589 594 (Pubitemid 30129471)
17. Satoh H., Kurishima K., Ishikawa H., Ohtsuka M., Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases Journal of Internal Medicine 2006 260 5 429 434 (Pubitemid 44571130)
18. Sakamoto K., Taniguchi H., Kondoh Y., Johkoh T., Sumikawa H., Kimura T., Nishiyama O., Kato K., Kataoka K., Ono K., Kitaichi M., Hasegawa Y., Serum KL-6 in fibrotic NSIP: correlations with physiologic and radiologic parameters Respiratory Medicine 2010 104 1 127 133
19. Greene K. E., King T. E., Kuroki Y., Bucher-Bartelson B., Hunninghake G. W., Newman L. S., Nagae H., Mason R. J., Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis European Respiratory Journal 2002 19 3 439 446 (Pubitemid 34256957)
20. Takahashi H., Fujishima T., Koba H., Murakami S., Kurokawa K., Shibuya Y., Shiratori M., Kuroki Y., Abe S., Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent American Journal of Respiratory and Critical Care Medicine 2000 162 3 1109 1114
21. Latsi P. I., Du Bois R. M., Nicholson A. G., Colby T. V., Bisirtzoglou D., Nikolakopoulou A., Veeraraghavan S., Hansell D. M., Wells A. U., Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends American Journal of Respiratory and Critical Care Medicine 2003 168 5 531 537 (Pubitemid 37088594)
22. Behr J., Demedts M., Buhl R., Costabel U., Dekhuijzen R. P., Jansen H. M., MacNee W., Thomeer M., Wallaert B., Laurent F., Nicholson A. G., Verbeken E. K., Verschakelen J., Flower C. D., Petruzzelli S., De Vuyst P., van den Bosch J. M., Rodriguez-Becerra E., Lankhorst I., Sardina M., Boissard G., Lung function in idiopathic pulmonary fibrosisextended analyses of the IFIGENIA trial Respiratory Research 2009 10 101
23. Hisata S., Kimura Y., Shibata N., A normal range of KL-6/MUC1 independent of elevated SP-D indicates a better prognosis in the patients with honeycombing on high-resolution computed tomography Pulmonary Medicine 2011 2011 7